Anthranilamide

Anthranilamide

SCHEMBL6444259

CN(C)CCOc1cccc2cc(C(=O)O)oc12.NC(=O)c1ccccc1N

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
ALDH1A1 P00352 6/20 0.46
KMT2A Q03164 3/20 0.46
HTR1B P28222 1/20 0.41
MEN1 O00255 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
ADORA2A P29274 1/20 0.40
ADORA2B P29275 1/20 0.40
ADORA1 P30542 1/20 0.40
KDM4E B2RXH2 4/20 0.40
CSF1R P07333 1/20 0.39
HRH1 P35367 1/20 0.39
LMNA P02545 1/20 0.39
RECQL P46063 1/20 0.39
DYRK3 O43781 1/20 0.39
MAP4K4 O95819 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6444273 0.92 HTR1B (0.46) CYP1A2CYP3A4CYP2C19ALDH1A1KMT2A
SCHEMBL5559604 0.87 LMNA (0.49) ALDH1A1KMT2AHTR1BMEN1SMN1; SMN2
Anthranilamide SCHEMBL6280290 0.83 KMT2A (0.67) CYP1A2CYP3A4CYP2C19ALDH1A1KMT2A
SCHEMBL5559227 0.82 HTR1B (0.50) ALDH1A1KMT2AHTR1BMEN1SMN1; SMN2
SCHEMBL6444267 0.79 RAB9A (0.47) ALDH1A1KMT2AHTR1BSMN1; SMN2NPC1
SCHEMBL5565039 0.76 LMNA (0.46) CYP1A2CYP3A4CYP2C19ALDH1A1KMT2A
SCHEMBL6982551 0.75 MAPK1 (0.49) CYP1A2CYP3A4CYP2C19ALDH1A1KMT2A
SCHEMBL6280297 0.74 KMT2A (0.68) ALDH1A1KMT2AMEN1SMN1; SMN2NPC1
SCHEMBL5565438 0.74 LMNA (0.55) ALDH1A1KMT2AMEN1SMN1; SMN2NPC1
SCHEMBL5558971 0.73 LMNA (0.50) CYP1A2CYP3A4CYP2C19ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1594857-A2 N-MONOACYLATED O-PHENYLENEDIAMINES AS ANTI-CANCER AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2005-11-16 EP claimed
WO-2004069133-A2 N-MONOACYLATED O-PHENYLENEDIAMINES AS ANTI -CANCER AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2004-08-19 WO claimed